These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3835791)

  • 1. [Studies on drugs used for the treatment of hyperlipoproteinemia:synthesis of new aryloxyisobutyric acid derivatives].
    Zhang Y; Wang HC
    Yao Xue Xue Bao; 1985 Nov; 20(11):827-31. PubMed ID: 3835791
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
    Metz G; Specker M
    Arzneimittelforschung; 1980; 30(11b):2014-9. PubMed ID: 7194051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amino acid derivatives of 2-(p-chlorophenoxy)-2-methylpropionic acid as compounds with potential antilipemic agents. II. Preparation of methyl esters of N-[2-(p-chlorophenoxy)-2-methylpropionyl] amino acids].
    Kwapiszewski W; Borkowski L
    Acta Pol Pharm; 1987; 44(2):121-31. PubMed ID: 3434313
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new clofibrate analogues as potential PPARalpha agonists.
    Perrone MG; Santandrea E; Dell'Uomo N; Giannessi F; Milazzo FM; Sciarroni AF; Scilimati A; Tortorella V
    Eur J Med Chem; 2005 Feb; 40(2):143-54. PubMed ID: 15694649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
    Ribalta JM; Artús JJ; Salvador L; Roma E; Vilageliu J; Freixes J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1782-6. PubMed ID: 6797442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
    Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
    Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
    Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
    Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
    [No Abstract]   [Full Text] [Related]  

  • 9. Azidofibrate. Synthesis and evaluation of its effects on fat cell lipolysis in vitro.
    Gaion RM; Pozzo-Balbi T; Nobile L; Da Re P
    Arzneimittelforschung; 1982; 32(3):186-9. PubMed ID: 7200777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fenofibrate: chemical development and differences with clofibrate (author's transl)].
    Boucherle A
    Nouv Presse Med; 1980 Dec; 9(49):3721-3. PubMed ID: 7208336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aryloxy- and arylthioalkylamine hypolipidemic agents].
    Duranti E; Bonifazi P; Salvatori A; Balsamini C; Peruzzi G; Cantoni O
    Farmaco Sci; 1983 Sep; 38(9):664-71. PubMed ID: 6641932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/activity relationship of gemfibrozil (CI-719) and related compounds.
    Creger PL; Moersch GW; Neuklis WA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):3-5. PubMed ID: 1019152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J; Vinzia C; Gómez JM; Morató J
    Med Clin (Barc); 1984 May; 82(19):840-2. PubMed ID: 6738212
    [No Abstract]   [Full Text] [Related]  

  • 14. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
    Altomonte L; Mingrone G; Negrini A; De Cunto F; Greco AV
    Clin Ter; 1981 Jan; 96(1):31-8. PubMed ID: 7016409
    [No Abstract]   [Full Text] [Related]  

  • 15. The synthesis of 2-methyl-5-(2', 2', 3'-trimethylcyclopentyl)-pentane-1-carboxylic acid.
    Zawisza T
    Pol J Pharmacol Pharm; 1974; 26(5):531-6. PubMed ID: 4427814
    [No Abstract]   [Full Text] [Related]  

  • 16. Xanthone analogues of clofibrate / Synthesis and biological evaluation as antagonists of lipolysis in vitro.
    Gaion RM; Valenti P; Montanari P; Da Re P
    Arzneimittelforschung; 1982; 32(5):499-502. PubMed ID: 7201826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV; Metz G
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypolipemic effect of amino acid derivatives of clofibric acid].
    Wójcicki J; Samochowiec L; Gawrońska-Szklarz B; Kwapiszewski W; Borkowski L
    Acta Pol Pharm; 1985; 42(3):305-8. PubMed ID: 4096253
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthesis and hypotriglyceridemic effect of various 2-phenylthis-3-pyridinesulfonamides].
    Delarge J; Ghys A
    Farmaco Sci; 1983 Jan; 38(1):9-14. PubMed ID: 6825834
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological basis for the therapeutic utilisation of hypolipedmic effects of clofibrate (author's transl)].
    Chevais M
    Therapie; 1980; 35(1):5-22. PubMed ID: 6998038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.